tiprankstipranks
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Financial Statements

2 Followers

VitaSpring Biomedical Financial Overview

VitaSpring Biomedical's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; VitaSpring Biomedical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 22Jul 22Apr 22Jan 22Oct 21
Income Statement-
Total Revenue--$ 1.49M$ 3.49M$ 200.40K
Gross Profit--$ 568.00K$ 1.47M$ 20.00K
EBIT$ 1.27K-$ 343.53K$ 1.19M$ -137.02K
EBITDA$ 5.04K$ 3.77K$ 347.30K$ 1.19M$ -133.26K
Net Income Common Stockholders$ -182.31K$ 30.33K$ 276.66K$ 941.37K$ -137.45K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.66K$ 39.20K$ 79.15K$ 107.21K$ 214.06K
Total Assets$ 2.44M$ 2.58M$ 2.70M$ 3.60M$ 1.14M
Total Debt$ 45.90K$ 91.77K$ 419.55K$ 463.57K$ 507.55K
Net Debt$ 4.24K$ 52.57K$ 340.40K$ 356.36K$ 293.50K
Total Liabilities$ 761.79K$ 801.63K$ 806.01K$ 2.03M$ 602.22K
Stockholders Equity$ 1.68M$ 1.78M$ 1.89M$ 1.58M$ 542.14K
Cash Flow-
Free Cash Flow$ -2.46K$ 113.68K$ -28.06K$ -156.84K$ -400.01K
Operating Cash Flow$ -2.46K$ 113.68K$ -28.06K$ -156.84K$ -376.80K
Investing Cash Flow$ -191.60K$ 70.00K-$ -1.00$ -23.21K
Financing Cash Flow-----
Currency in USD

VitaSpring Biomedical Earnings and Revenue History

VitaSpring Biomedical Debt to Assets

VitaSpring Biomedical Cash Flow

VitaSpring Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis